FDA approves children's dose of brain cancer drug

The US Food and Drug Administration (FDA) has approved a pediatric form of Afinitor (everolimus) to treat children with a brain tumor called subependymal giant cell astrocytoma. It’s called Afinitor Disperz. This is the first time the FDA has approved a form and dose of a drug specifically to treat a tumor that mainly affects children. Read more here.